Graphene Biosensors.
The ultimate tool for pandemic, epidemic and endemic preparedness
Graphene Biosensors.
Graphene biosensors are devices that use graphene's unique properties as the base for detection of biological or chemical substances with extreme sensitivity.
Graphene Solutions uses our partner, GLC Medical's, patented technology to create a highly accurate, portable, sensitive and digital diagnostic platform for pathogens that provides immediate results in under 1-minute and is easily deployable to any community around the globe.
The company already adheres to several of the UN Sustainable Development Goals, highlighting good health, partnerships, innovation and sustainable development goals.
The Gs2+ Biosensor Platform is a tool for pandemic, epidemic and endemic preparedness.
- Testing should generate fast and precise results - in under 1-minute.
- Sample collection should be non-invasive to encourage more testing to better understand the virus to manage, treat and stop the spread;
- Digital reading and reporting of data with the ability to read and report results digitally through cloud capabilities, enabling efficient data management and predictive software analysis;
- The test should be portable and user-friendly with the capability to deploy into any community around the globe;
- The capability to simultaneously test multiple samples and pathogens, to reduce the individual test time to results;
- This testing technology is our Biosensor Platform and it is a tool for pandemic, epidemic and endemic preparedness.
OUR FUTURE FOCUS
Graphene Solutions is focused on our future potential, which is huge! We will be adapting our Biosensor Platform for different pathogens, developing and customizing cost-saving multiplex testing for detection of several pathogens simultaneously, and creating commercial value through real-world deployment into a global market, unrestricted by unavailability of on site clinics, thus serving remote communities and preventing the spread of disease to urban populations.
Other pathogens we can adapt the “Gs2+” to detect in partnership with world class lab partner in Mauritius are:
- Tuberculosis
- E-Coli
- Salmonella
- Influenza A/B
- Ebola
- Zika
- Chikungunya
- Cancer markers and more.
These biosensors can aid in curbing the spread of the virus, reducing healthcare costs associated with hospitalizations, and facilitating the safe reopening of economies.
The market potential for global care PoC diagnostics continues to be substantial with an anticipated growth to $49 billion by 2029, with a high demand for reliable and portable testing devices across various sectors, including healthcare, travel, and workplace safety.
The development of cost-effective, sensitive, and user-friendly biosensors has the potential to have a transformative impact on public health and the global economy.
1. Healthcare and medical applications
- Point-of-care diagnostics: Enabling fast, affordable, and non-invasive diagnostic tests for conditions like cancer, infectious diseases, and chronic illnesses.
- Genetic analysis: High-throughput analysis of DNA sequences for genetic research and personalized medicine.
- Wearable sensors: Graphene's flexibility allows for the creation of wearable devices that continuously monitor physiological signs like glucose levels, electrolytes in sweat, or pH.
- Disease monitoring: Tracking biomarkers for various diseases and enabling real-time monitoring for telemedicine.
2. Environmental and food safety applications
-
Contaminant detection: Highly sensitive detection of poisons, environmental toxins, and pollutants in air and water.
- Food quality: Used in the food industry for improved sorting and detecting pathogens like E. coli or Salmonella in food and beverages.
Infectious agent detection: Can detect infectious agents like bacteria in environmental samples.
3. Other applications
- High-throughput screening: Ideal for applications requiring the MULTIPLEX analysis of many samples quickly, such as drug discovery or research.
- Biomarker identification: Use for the identification of various biomolecules, including biomarkers for specific diseases.